Molina Healthcare, Inc. (NYSE:MOH) Given Consensus Rating of “Hold” by Brokerages

Shares of Molina Healthcare, Inc. (NYSE:MOHGet Free Report) have earned an average rating of “Hold” from the thirteen analysts that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $378.00.

Several research analysts have recently commented on the company. JPMorgan Chase & Co. lowered their price target on Molina Healthcare from $420.00 to $395.00 and set an “overweight” rating for the company in a research report on Wednesday, July 10th. Baird R W raised Molina Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. Truist Financial reduced their price target on shares of Molina Healthcare from $440.00 to $400.00 and set a “buy” rating on the stock in a research report on Monday, July 15th. Jefferies Financial Group lowered their price objective on shares of Molina Healthcare from $354.00 to $297.00 and set a “hold” rating for the company in a research note on Wednesday, July 24th. Finally, Deutsche Bank Aktiengesellschaft cut their target price on shares of Molina Healthcare from $354.00 to $353.00 and set a “hold” rating on the stock in a research note on Monday, July 29th.

View Our Latest Research Report on MOH

Molina Healthcare Trading Up 0.7 %

NYSE MOH opened at $360.77 on Tuesday. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.57 and a quick ratio of 1.57. The stock has a market capitalization of $21.14 billion, a P/E ratio of 19.58, a PEG ratio of 1.20 and a beta of 0.57. The firm’s 50-day moving average is $330.56 and its two-hundred day moving average is $343.80. Molina Healthcare has a 12 month low of $282.96 and a 12 month high of $423.92.

Molina Healthcare (NYSE:MOHGet Free Report) last issued its quarterly earnings data on Wednesday, July 24th. The company reported $5.86 EPS for the quarter, topping the consensus estimate of $5.73 by $0.13. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The firm had revenue of $9.88 billion for the quarter, compared to analyst estimates of $9.75 billion. During the same period in the prior year, the business posted $5.65 EPS. The business’s revenue for the quarter was up 18.7% compared to the same quarter last year. On average, sell-side analysts anticipate that Molina Healthcare will post 23.5 earnings per share for the current year.

Insider Transactions at Molina Healthcare

In related news, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the transaction, the director now owns 18,025 shares of the company’s stock, valued at $6,114,260.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In related news, Director Steven J. Orlando sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the completion of the transaction, the director now directly owns 18,025 shares of the company’s stock, valued at $6,114,260.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Maurice Hebert sold 393 shares of the stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total transaction of $136,182.36. Following the completion of the transaction, the chief accounting officer now owns 9,473 shares in the company, valued at $3,282,583.96. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company’s stock.

Institutional Investors Weigh In On Molina Healthcare

A number of institutional investors and hedge funds have recently bought and sold shares of MOH. Innealta Capital LLC acquired a new stake in shares of Molina Healthcare during the second quarter worth about $36,000. Ashton Thomas Private Wealth LLC acquired a new position in Molina Healthcare during the second quarter worth approximately $40,000. Principal Securities Inc. acquired a new position in Molina Healthcare during the fourth quarter worth approximately $42,000. AM Squared Ltd purchased a new stake in Molina Healthcare in the second quarter valued at approximately $59,000. Finally, Mather Group LLC. acquired a new stake in shares of Molina Healthcare in the first quarter valued at approximately $123,000. 98.50% of the stock is owned by hedge funds and other institutional investors.

Molina Healthcare Company Profile

(Get Free Report

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Read More

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.